Summary
Neuropathological examination has remained the most important tool to give a definite diagnosis of human transmissible sppngiform encephalopathies (TSEs). In recent years, immunohistochemistry (IHC) for the disease-associated prion protein (PrP) has emerged as an indispensable adjunct to the neuropathological confirmation of TSEs, especially in cases with equivocal histopathologipal changes. The clinico-pathological pheno-type including histopathology and IHC for PrP depends upon PrPres fragment size and codon 129 geiiptype in the PrP gene, PRNP. However, some TSEs have little or no spongiform change pr detectable PrP, such as fatal familial insomnia (FFI), IHC for PrP requires appropriate techniqup, has some pitfalls and thus should be interpreted by experienced observers. The amount and distribution of PrP deposits do not always cprrelate with type and severity of local tissue damage. PrP deposition occurs only where neuronal parenchyma is present; in pre-existing tissue lesions such as scarred infarctions with prominent gliosis, PrP does not accumulate. Most recently, new patterns of granular ganglionic and tiny adaxonal PrP deposits were described in the peripheral nervous system in rare human TSE cases and experimental scrapie. There is early, severe and selective loss of a peculiar parvalbumin-expressing subset of inhibitory GABAergic neurons both in human and experimental TSEs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Almer G, Hainfellner JA, Brücke T, Jellinger K, Kleinert R, Bayer G, Windl O, Kretzschmar HA, Hill A, Sidle K, Collinge J, Budka H (1999) Fatal familial insomnia: a new Austrian family. Brain 122: 5–16
Belichenko PV, Miklossy J, Belser B, Budka H, Celio MR (1999) Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease. Neurobiol Dis 6: 269–279
Bell JE, Gentleman SM, Ironside JW, McCardle L, Lantos PL, Doey L, Lowe J, Fergusson J, Luthert P, McQuaid S, Allen IV (1997) Prion protein immunocyto-chemistry-UK five centre consensus report. Neuropathol Appl Neurobiol 23:26–35
Budka H (1997) The human prion diseases: from neuropathology to pathobiology and molecular genetics. Final report of an EU Concerted Action. Neuropathol Appl Neurobiol 23: 416–422
Budka H (1997) Transmissible spongiform encephalopathies (prion diseases). In: Garcia JH (ed) Neuropathology. The diagnostic approach. Mosby, St. Louis, pp 449–474
Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J, Weller RO (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5: 459–466
Dorandeu A, Wingertsmann L, Chrétien F, Delisle M-B, Vital C, Parchi P, Montagna P, Lugaresi E, Ironside JW, Budka H, Gambetti P, Gray F (1998) Neuronal apoptosis in fatal familial insomnia. Brain Pathol 8: 531–537
Giaccone G, Canciani B, Puoti G, Rossi G, Goffredo D, Iussich S, Fociani P, Tagliavini F, Bugiani O (2000) Creutzfeldt-Jakob disease: Carnoy’s fixative improves the immunohistochemistry of the proteinase K-resistant prion protein. Brain Pathol 10: 31–37
Groschup MH, Beekes M, McBride PA, Hardt M, Hainfellner JA, Budka H (1999) Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie. Acta Neuropathol 98: 453–457
Guentchev M, Groschup MH, Kordek R, Liberski PP, Budka H (1998) Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol 8: 615–623
Guentchev M, Hainfellner J-A, Trabattoni GR, Budka H (1997) Distribution of parvalbumin positive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 56: 1119–1124
Guentchev M, Wanschitz J, Voigtlaender T, Flicker H, Budka H (1999) Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases. Am J Pathol 155: 1453–1457
Hainfellner JA, Brantner-Inthaler S, Cervenakova L, Brown P, Kitamotd T, Tateishi J, Diringer H, Liberski PP, Regele H, Feucht M, Mayr N, Wessely P, Summer K, Seitelberger F, Budka H (1995) The original Gerstmaim-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 5: 201–211
Hainfellner JA, Budka H (1996) Immunomorphology of human prion diseases. In: Court L, Dodet B (eds) Transmissible spongiform encephalopathies: prion diseases. Elsevier, Paris, pp 75–80
Hainfellner JA, Budka H (1999) Disease associated prion protein may deposit in the peripheral nçrvous system in human transmissible spongiforjn encephalopathies. Acta Neuropathol 98: 458–460
Hainfellner JA, Jellinger K, Diringer H, Guentchev M, Kleinert R, Pilz P, Maier H, Budka H (1996) Creutzfeldt-Jakob disease in Austria. J Neurol Neurosurg Psychiatry 61: 139–142
Hegyi I, Hainfellner JA, Flicker H, Ironside JW, Hauw JJ, Tateishi J, Haltia M, Bügiani O, Aguzzi A, Budka H (1997) Prion protein immunocytochemifstry: reliable staining protocol, immunomorphology, and diagnostic pitfalls. Clin Neuropathol 16: 262–263
Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, Frosh A, Tolley N, Bell JE, Spencer M, King A, Al-Sarraj S, Ironside JW, Lantos PL, Collinge J (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353: 183–189
Kordek R, Hainfellner JA, Liberski PP, Budka H (1999) Deposition of the prion protein (PrP) during the evolution of experimental Creutzfeldt-Jakob disease. Acta Neuropathol 98: 597–602
Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J (1996) Diagnostic criteria for sporadic Creutzfeldt-Jakob-disease. Arch Neurol 53: 913–920
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224–233
Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156: 51–50
Van Everbroeck B, Palsa P, Martina J-J, Cras P (1999) Antigen retrieval in prion protein immunohistophemistry. J Mistochem Cytochem 47: 1465–1470
WHO (1998) Global surveillance, diagnosis and therapy of human transmissible spongiforpi encephalopathies: report of a WHO consultation. Geneva, Switzerland, 9–11 February 1998. WHO, Geneva
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Wien
About this chapter
Cite this chapter
Budka, H. (2000). Histopathology and immunohistochemistry of human transmissible spongiform encephalopathies (TSEs). In: Groschup, M.H., Kretzschmar, H.A. (eds) Prion Diseases. Archives of Virology. Supplementa, vol 16. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6308-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6308-5_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83529-6
Online ISBN: 978-3-7091-6308-5
eBook Packages: Springer Book Archive